US 6,789,027 C14

URI: https://gptkb.org/entity/US_6%2C789%2C027_C14

GPTKB entity

Statements (65)

Predicate	Object
gptkbp:instanceOf	patent
gptkbp:abstract	A method for treating disease.
gptkbp:applicationNumber	10/123,456
gptkbp:applicationType	non-provisional
gptkbp:assignee	gptkb:Acme_Corporation
gptkbp:citedBy	gptkb:US_7,123,456_B2
gptkbp:claims	20
gptkbp:class	A61K
gptkbp:description	This patent describes a novel compound.
gptkbp:examiner	Jane_Smith
gptkbp:expirationDate	September 7, 2024
gptkbp:fieldOfUse	pharmaceuticals
gptkbp:filingDate	April 15, 2002
gptkbp:grantDate	September 7, 2004
gptkbp:hasResearchInterest	medicinal chemistry
https://www.w3.org/2000/01/rdf-schema#label	US 6,789,027 C14
gptkbp:internationalClassification	C07D 401/12
gptkbp:inventor	gptkb:John_Doe
gptkbp:inventorCountry	gptkb:USA
gptkbp:issuedOn	September 7, 2004
gptkbp:legalStatus	granted
gptkbp:location	gptkb:United_States
gptkbp:patentCitation	gptkb:US_7,890,123_C2 gptkb:US_5,678,901_A gptkb:US_6,543,210_B1 US_8,765,432_B3 US_9,876,543_B4
gptkbp:patentFamily	gptkb:US_6,789,027
gptkbp:patentFamilyMembers	gptkb:US_6,789,040_C27 gptkb:US_6,789,043_C30 gptkb:US_6,789,028_C15 gptkb:US_6,789,048_C35 gptkb:US_6,789,042_C29 gptkb:US_6,789,039_C26 gptkb:US_6,789,034_C21 gptkb:US_6,789,033_C20 gptkb:US_6,789,049_C36 gptkb:US_6,789,045_C32 gptkb:US_6,789,036_C23 gptkb:US_6,789,046_C33 gptkb:US_6,789,030_C17 gptkb:US_6,789,047_C34 gptkb:US_6,789,037_C24 US 6,789,038 C25 US_6,789,031_C18 US_6,789,029_C16 US_6,789,032_C19 US_6,789,035_C22 US_6,789,041_C28 US_6,789,044_C31 US_6,789,050_C37
gptkbp:patentNumber	6,789,027
gptkbp:patentOffice	gptkb:USPTO
gptkbp:patentStatus	active
gptkbp:patentType	granted utility
gptkbp:priorityDate	March 15, 2001
gptkbp:publicationNumber	2003/0123456 A1
gptkbp:relatedPatent	gptkb:US_6,789,028_C15
gptkbp:relatedTo	gptkb:US_6,789,026_C13
gptkbp:research	NIH
gptkbp:researchInterest	gptkb:Harvard_University
gptkbp:status	active
gptkbp:subclass	A61K 31/00
gptkbp:technology	biotechnology